HCA Healthcare Inc. (NYSE:HCA)

An analysis of the valuation multiples from 2017 to 2021 reveals fluctuating market sentiments and shifting valuation benchmarks. While some ratios showed a general upward trend over the five-year period, there was a notable contraction in earnings-based multiples by the end of the observed timeframe.

Price to Earnings (P/E)

The P/E ratio demonstrated volatility, starting at 15.92 in 2017 and experiencing a dip in 2018 before climbing to a peak of 16.06 in 2020. A sharp decline followed in 2021, where the ratio dropped to 10.65, the lowest level in the five-year sequence, suggesting a compression in the earnings multiple.

Price to Operating Profit (P/OP)

A growth trend was observed in the P/OP ratio from 2017 through 2020, rising from 5.82 to a high of 8.31. Similar to the P/E ratio, this trend reversed in 2021, with the ratio retreating to 6.56, indicating a reduction in the valuation relative to operating profitability.

Price to Sales (P/S)

The P/S ratio exhibited the most consistent growth of the analyzed metrics. Excluding a marginal decrease in 2019, the ratio climbed steadily from 0.81 in 2017 to 1.26 in 2021. This progression indicates that the market assigned an increasing value to each dollar of revenue generated over the period.

Price to Book Value (P/BV)

Available data for the P/BV ratio is limited to the year 2020, which shows an exceptionally high value of 105.40. This suggests a significant disparity between the market capitalization and the book value of the equity during that period.

Between 2017 and 2021, a consistent upward trajectory in share price and earnings per share was observed, although the price-to-earnings ratio exhibited significant fluctuations. The most notable shift occurred in 2021, where profitability growth substantially outpaced share price appreciation, leading to a contraction in the valuation multiple.

Share Price Trends

The share price demonstrated an uninterrupted annual increase over the five-year period, rising from 100.84 USD in 2017 to 244.10 USD by 2021. This represents a total increase of approximately 142%, with the most aggressive growth occurring between 2020 and 2021.

Earnings Per Share (EPS) Performance

Earnings per share experienced a sharp initial increase from 6.33 USD in 2017 to 11.06 USD in 2018. Following a period of relative stability between 2018 and 2020, where values fluctuated slightly around 11.00 USD, a substantial surge was recorded in 2021, with EPS reaching 22.91 USD, more than doubling the previous year's performance.

Price-to-Earnings (P/E) Ratio Analysis

The P/E ratio did not follow the linear growth seen in price and earnings. It decreased from 15.92 in 2017 to 12.84 in 2018, before rising to a period peak of 16.06 in 2020. In 2021, the ratio dropped to its lowest level of 10.65. This decline occurred because the growth in EPS significantly exceeded the growth in the share price, suggesting that the market valuation of the stock became more conservative relative to its actual earnings power by the end of the period.

Between 2017 and 2021, the valuation metrics reflect a period of significant growth in both equity pricing and operational earnings, characterized by a notable shift in the valuation multiple during the final two years of the period.

Share Price Appreciation

A consistent upward trend is observed in the share price, which climbed from 100.84 US$ in 2017 to 244.10 US$ by the end of 2021. The growth was relatively steady between 2017 and 2019, followed by a more aggressive acceleration from 2020 to 2021, where the price increased by approximately 37.6%.

Operating Profit Per Share Performance

Operating profit per share rose from 17.33 US$ in 2017 to 21.38 US$ in 2019. A period of stagnation occurred in 2020, with a marginal decline to 21.34 US$. This was followed by a substantial surge in 2021, with profit per share reaching 37.21 US$, indicating a significant expansion in operational profitability.

Price to Operating Profit (P/OP) Analysis

The P/OP ratio experienced moderate expansion from 5.82 in 2017 to 6.93 in 2019. A peak valuation multiple of 8.31 was reached in 2020, which coincided with a rising share price and flat operating profits. In 2021, the ratio compressed to 6.56; this decline occurred because the growth in operating profit per share significantly outpaced the increase in the share price, resulting in a lower multiple despite the higher nominal stock value.

An analysis of the valuation metrics from 2017 to 2021 reveals a consistent expansion in the market valuation of the common stock relative to its revenue generation. The Price-to-Sales (P/S) ratio transitioned from a sub-1.0 level to a higher multiple, indicating an increase in the premium investors were willing to pay for each dollar of sales.

Share Price Appreciation

A strong and continuous upward trend is observed in the share price, which rose from 100.84 US$ in 2017 to 244.10 US$ by the end of 2021. The most significant acceleration occurred between 2020 and 2021, where the price increased by approximately 37.6%.

Sales per Share Growth

Revenue efficiency on a per-share basis demonstrated steady growth, increasing from 124.65 US$ in 2017 to 193.52 US$ in 2021. A period of stagnation is noted between 2019 and 2020, where sales per share remained virtually flat at approximately 151.60 US$, before resuming a sharp increase in 2021.

Price-to-Sales (P/S) Ratio Dynamics

The P/S ratio increased from 0.81 in 2017 to 1.26 in 2021. Although a slight contraction occurred in 2019 (dropping to 0.98), the overall trajectory was positive. The expansion of this ratio suggests that share price growth outpaced the growth in sales per share over the five-year period, reflecting enhanced market confidence or a shift in valuation benchmarks.

The financial data reveals a significant divergence between the market valuation of the shares and the accounting book value over the five-year period from 2017 to 2021. While the market price experienced consistent and substantial growth, the book value per share remained largely negative, reflecting a capital structure that often carries liabilities exceeding assets.

Share Price Trend

A strong upward trajectory is observed in the share price, which rose from 100.84 US$ in 2017 to 244.10 US$ by 2021. This represents a steady increase in market capitalization and investor demand throughout the analyzed timeframe.

Book Value per Share (BVPS) Dynamics

The BVPS exhibited significant volatility and remained negative for four of the five years. An improving trend was noted between 2017 and 2020, as the value moved from -19.45 US$ to a positive 1.68 US$. However, this progress was reversed in 2021, when the BVPS declined again to -3.07 US$.

Price to Book Value (P/BV) Interpretation

The P/BV ratio is absent for most of the period, as the ratio is generally considered non-meaningful when book value is negative. The sole reported ratio of 105.40 in 2020 coincides with the only year of positive BVPS. This exceptionally high multiple indicates that the market valuation was based on factors far beyond the accounting net asset value, such as projected earnings growth, intangible assets, or strategic market positioning.